681 related articles for article (PubMed ID: 19333922)
1. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
2. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
[TBL] [Abstract][Full Text] [Related]
3. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
4. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
5. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.
Luo X; Yang W; Ye DQ; Cui H; Zhang Y; Hirankarn N; Qian X; Tang Y; Lau YL; de Vries N; Tak PP; Tsao BP; Shen N
PLoS Genet; 2011 Jun; 7(6):e1002128. PubMed ID: 21738483
[TBL] [Abstract][Full Text] [Related]
6. Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus.
Dominguez-Gutierrez PR; Ceribelli A; Satoh M; Sobel ES; Reeves WH; Chan EK
J Clin Immunol; 2014 Feb; 34(2):171-80. PubMed ID: 24292724
[TBL] [Abstract][Full Text] [Related]
7. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
Hai-yan W; Yang L; Mei-hong C; Hui Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):185-8. PubMed ID: 21529448
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon Pathway.
Zhu X; Zhang Y; Yin Z; Ye Z; Qin Y; Cheng Z; Shen Y; Yin Z; Ma J; Tang Y; Ding H; Guo Y; Hou G; Shen N
Arthritis Rheumatol; 2024 Mar; 76(3):384-395. PubMed ID: 37728419
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
Front Immunol; 2021; 12():747616. PubMed ID: 34745118
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
[TBL] [Abstract][Full Text] [Related]
12. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
Wang X; Zhang C; Wu Z; Chen Y; Shi W
Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
[TBL] [Abstract][Full Text] [Related]
13. Identification of LncRNA Linc00513 Containing Lupus-Associated Genetic Variants as a Novel Regulator of Interferon Signaling Pathway.
Xue Z; Cui C; Liao Z; Xia S; Zhang P; Qin J; Guo Q; Chen S; Fu Q; Yin Z; Ye Z; Tang Y; Shen N
Front Immunol; 2018; 9():2967. PubMed ID: 30619325
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-448 suppresses CD4
Zhang J; Guo Y; Sun Y; Chang L; Wang X
Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
[TBL] [Abstract][Full Text] [Related]
16. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.
Pan Y; Jia T; Zhang Y; Zhang K; Zhang R; Li J; Wang L
Int J Nanomedicine; 2012; 7():5957-67. PubMed ID: 23233803
[TBL] [Abstract][Full Text] [Related]
17. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
18. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
19. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
20. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2.
Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D
Front Immunol; 2021; 12():756825. PubMed ID: 34721432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
